For the fifth year in a row, use of most substances among teenagers in the United States remains near the low point reached in 2021. The finding comes from the Monitoring the Future survey at the University of Michigan. The survey is done every year and has had support from the National Institutes of Health for many years.
The survey asks eighth, tenth and twelfth graders about substance use in the past month and year, and about harm and availability. In 2025 most measures stayed about the same as in 2024. Investigators collected answers from many schools and made the results representative for the whole country.
Difficult words
- substance — a chemical, drug, or material people can usesubstances
- survey — a study that asks people questions
- harm — physical or mental damage or hurt
- availability — how easy something is to get
- representative — true for the larger group or population
- investigator — a person who studies facts and collects informationInvestigators
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Why is it useful that the survey is done every year?
- How might collecting answers from many schools help the results?
- Do you think questions about harm and availability are important? Why or why not?
Related articles
Study: Year‑round RSV Immunization Could Reduce Big Outbreaks
A study in Science Advances finds that offering RSV immunizations year‑round would lower the chance of large seasonal outbreaks in the United States. Researchers compared spread in cities and rural areas and tested seasonal versus year‑round schedules.
Emory study: 2023–24 COVID vaccine gives lasting antibodies
Emory University measured antibody responses in 24 people after the 2023–24 monovalent vaccine targeting Omicron XBB.1.5. The study found long-lasting antibodies, cross-reactive protection with the ancestral WA1 strain, and a 2.8-fold boost from immune imprinting.
Biodegradable patch may help heart heal after heart attack
Researchers report a biodegradable microneedle patch that delivers interleukin-4 to injured heart tissue. The local treatment encourages healing immune cells, reduces scarring, and may improve heart recovery while avoiding systemic side effects.
Lower chemotherapy dose helps people 80+ with lymphoma
A study found that people aged 80 and older with a common lymphoma often do better with a lower chemotherapy dose. Researchers used data from community cancer clinics and say the smaller dose kept effectiveness while reducing side effects.